Ultralife (NASDAQ:ULBI) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.15 by 93.33 percent. This is a 94.44 percent decrease over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $43.90 million which beat the analyst consensus estimate of $40.00 million by 9.75 percent. This is a 1.45 percent decrease over sales of $44.55 million the same period last year.